Literature DB >> 20706994

Maternal diabetes and renal agenesis/dysgenesis.

Erin M Davis1, Jennifer David Peck, David Thompson, Robert A Wild, Peter Langlois.   

Abstract

BACKGROUND: Renal agenesis and dysgenesis are potentially lethal congenital malformations affecting 2 to 5 infants per 10,000 live births annually in the United States. The low prevalence of these malformations has complicated understanding of potential risk factors. Maternal diabetes (type 1, type 2, and gestational) has been evaluated extensively as a risk factor for other congenital malformations, but only a limited number of studies have assessed the association between diabetes and renal agenesis.
METHODS: We conducted a population-based case-control study of deliveries after 20 weeks gestation in Texas Health Service Region 6 (Houston/Galveston area) from January 1, 2000 to December 31, 2002. Cases of renal agenesis/dysgenesis (n = 89) were ascertained from the Texas Birth Defects Registry. Cumulative incidence sampling was used to randomly select, from birth and fetal death records, 356 controls frequency matched to cases by delivery year and vital status. Maternal diabetes and other covariates were collected from vital records.
RESULTS: The odds of renal agenesis/dysgenesis were 3.1 (95% confidence interval [CI], 1.1-9.3) times greater among deliveries of mothers with diabetes compared to deliveries of mothers without diabetes, controlling for matching factors.
CONCLUSIONS: Our results are consistent with prior, but limited, research identifying diabetes as a risk factor for renal agenesis/dysgenesis. While these data did not differentiate diabetes diagnoses by type, the results suggest that maternal diabetes may be associated with renal malformations. Further study is warranted.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20706994     DOI: 10.1002/bdra.20702

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  8 in total

1.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

Review 2.  Evidence-based, ethically justified counseling for fetal bilateral renal agenesis.

Authors:  Alana N Thomas; Laurence B McCullough; Frank A Chervenak; Frank X Placencia
Journal:  J Perinat Med       Date:  2017-07-26       Impact factor: 1.901

3.  In utero exposure to maternal diabetes impairs nephron progenitor differentiation.

Authors:  Débora M Cerqueira; Shelby L Hemker; Andrew J Bodnar; Daniella M Ortiz; Favour O Oladipupo; Elina Mukherjee; Zhenwei Gong; Corynn Appolonia; Radhika Muzumdar; Sunder Sims-Lucas; Jacqueline Ho
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-11

4.  Ophthalmic Pathology in the Offspring of Pregnant Women with Gestational Diabetes Mellitus.

Authors:  Olga Alvarez-Bulnes; Anna Monés-Llivina; Lluís Cavero-Roig; Paula Sol Ventura; Josefina Llagostera-Benedico; Carme Valls-Sirera; Gemma Talló-Catarineu
Journal:  Matern Child Health J       Date:  2020-04

Review 5.  Assessment of nephron number and single-nephron glomerular filtration rate in a clinical setting.

Authors:  Nobuo Tsuboi; Takaya Sasaki; Yusuke Okabayashi; Kotaro Haruhara; Go Kanzaki; Takashi Yokoo
Journal:  Hypertens Res       Date:  2021-02-01       Impact factor: 3.872

6.  Complementary role of magnetic resonance imaging after ultrasound examination in assessing fetal renal agenesis: a case report.

Authors:  Tomasz Gęca; Arkadiusz Krzyżanowski; Aleksandra Stupak; Anna Kwaśniewska; Tomasz Pikuła; Radosław Pietura
Journal:  J Med Case Rep       Date:  2014-03-12

7.  A Systematic Review and Meta-Analysis of Diabetes During Pregnancy and Congenital Genitourinary Abnormalities.

Authors:  Mounika Parimi; Dorothea Nitsch
Journal:  Kidney Int Rep       Date:  2020-02-28

8.  Altered ureteric branching morphogenesis and nephron endowment in offspring of diabetic and insulin-treated pregnancy.

Authors:  Stacey N Hokke; James A Armitage; Victor G Puelles; Kieran M Short; Lynelle Jones; Ian M Smyth; John F Bertram; Luise A Cullen-McEwen
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.